The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab in patients with recurrent thymic carcinoma: Results of a phase II study.
 
Giuseppe Giaccone
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; G1 Therapeutics; Inivata
Research Funding - AstraZeneca; Karyopharm Therapeutics; Lilly
 
Jillian Thompson
No Relationships to Disclose
 
Colleen McGuire
No Relationships to Disclose
 
Maria Manning
No Relationships to Disclose
 
Bhaskar Kallakury
No Relationships to Disclose
 
Joeffrey J Chahine
No Relationships to Disclose
 
Deepa Suresh Subramaniam
No Relationships to Disclose
 
Stephen V. Liu
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim; Celgene; Genentech; Lilly; Pfizer
Research Funding - Bayer; Clovis Oncology; Corvus Pharmaceuticals; Esanex; Genentech/Roche; Ignyta; MedImmune; Merck; OncoMed; Pfizer; Threshold Pharmaceuticals
 
Geoffrey Thomas Gibney
Consulting or Advisory Role - Novartis
Speakers' Bureau - Merck
 
Chul Kim
No Relationships to Disclose
 
Justine N McCutcheon
No Relationships to Disclose